You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Idiopathic Pulmonary Fibrosis (IPF)

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis Trial in Durham (Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Hyperpolarized 129 Xenon Gas Comparing Idiopathic Pulmonary Fibrosis (IPF) Treatment
  • Durham, North Carolina
    Duke University Medical Center
May 3, 2022

Idiopathic Pulmonary Fibrosis Trial (BBT-877, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Jul 29, 2022

Idiopathic Pulmonary Fibrosis Trial in Hialeah Gardens (20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 20mM sodium pyruvate nasal spray
  • Saline Placebo control nasal spray
  • Hialeah Gardens, Florida
    Family First Medical Research Center
Sep 16, 2023

Idiopathic Pulmonary Fibrosis, Cough Trial in India (ME-015 (Suplatast Tosilate), Identical )

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Cough
  • ME-015 (Suplatast Tosilate)
  • Identical placebo
  • Guntur, Andhra Pradesh, India
  • +3 more
Aug 1, 2023

Idiopathic Pulmonary Fibrosis Trial in United States (ORIN1001, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Palm Springs, California
  • +11 more
Jul 7, 2022

Idiopathic Pulmonary Fibrosis Trial in Beijing (AK3280, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Beijing, Beijing, China
    China-Japan Friendship Hospital
Jul 19, 2022

Idiopathic Pulmonary Fibrosis (IPF) Trial (ANG-3070, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • (no location specified)
Jun 8, 2022

Nalbuphine, Idiopathic Pulmonary Fibrosis, Cough Trial in United Kingdom (Nalbuphine ER, Placebo oral tablet)

Completed
  • Nalbuphine
  • +2 more
  • Nalbuphine ER
  • Placebo oral tablet
  • Antrim, Northern Ireland, United Kingdom
  • +14 more
Oct 3, 2022

Idiopathic Pulmonary Fibrosis Trial in Stanford (Artesunate Oral Product)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • Artesunate Oral Product
  • Stanford, California
    Stanford University
Aug 4, 2023

Idiopathic Pulmonary Fibrosis Trial in Kingston (Nitric Oxide, Medical air)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Nitric Oxide
  • Medical air
  • Kingston, Ontario, Canada
    Respiratory Investigation Unit, Kingston General Hospital
Apr 21, 2022

Idiopathic Pulmonary Fibrosis (IPF) Trial in Shanghai (ZSP1603, Placebo)

Recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Shanghai, Shanghai, China
    Shanghai Lung Hospital
Nov 3, 2021

Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Jan 3, 2023

Obstructive Sleep Apnea and Idiopathic Pulmonary Fibrosis

Recruiting
  • OSA，IPF
  • IL-17A,S100A8
  • Tianjin, China
    Tianjin Medical University General Hospital
Apr 20, 2023

Idiopathic Pulmonary Fibrosis (IPF) Trial (XFB-19, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis (IPF)
  • (no location specified)
Jul 14, 2022

Idiopathic Pulmonary Fibrosis Trial in Boston, Durham, Leiden (PRM-151, Placebo)

Completed
Has Results
  • Idiopathic Pulmonary Fibrosis
  • PRM-151
  • Placebo
  • Boston, Massachusetts
  • +2 more
Mar 31, 2022

Idiopathic Pulmonary Fibrosis, IPF Trial in Izmir (Inspiratory Muscle Training (IMT), Sham IMT)

Completed
  • Idiopathic Pulmonary Fibrosis
  • IPF
  • Inspiratory Muscle Training (IMT)
  • Sham IMT
  • Izmir, Balcova, Turkey
    Dokuz Eylul University
Nov 6, 2022

Healthy Participants, Idiopathic Pulmonary Fibrosis (IPF) Trial in New Haven (18F-BMS-986327)

Recruiting
  • Healthy Participants
  • Idiopathic Pulmonary Fibrosis (IPF)
  • 18F-BMS-986327
  • New Haven, Connecticut
    Yale Positron Emission Tomography Center
Mar 30, 2022

Idiopathic Pulmonary Fibrosis Trial in United States

Active, not recruiting
  • Idiopathic Pulmonary Fibrosis
    • Baltimore, Maryland
    • +4 more
    Oct 29, 2021

    Idiopathic Pulmonary Fibrosis Trial in Zhengzhou (Jin-shui Huan-xian granule, Jin-shui Huan-xian granule )

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • Jin-shui Huan-xian granule
    • Jin-shui Huan-xian granule placebo
    • Zhengzhou, China
      the First Affiliated Hospital of Henan University of Chinese Med
    Aug 17, 2022

    Idiopathic Pulmonary Fibrosis (IPF) Trial in Manchester (TD-1058, Placebo)

    Terminated
    • Idiopathic Pulmonary Fibrosis (IPF)
    • Manchester, United Kingdom
      Theravance Biopharma Investigational Site
    Feb 7, 2022

    Idiopathic Pulmonary Fibrosis Trial in Seattle (12-week mHealth home exercise prescription)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
    • 12-week mHealth home exercise prescription
    • Seattle, Washington
      University of Washington
    Oct 4, 2021

    Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)

    Recruiting
    • Idiopathic Pulmonary Fibrosis
      • Pittsburgh, Pennsylvania
        University of Pittsburgh
      Nov 1, 2021

      Idiopathic Pulmonary Fibrosis Trial in San Francisco, Boston, New York (EGCG 300 mg + Nintedanib, EGCG 300 mg + Pirfenidone,

      Not yet recruiting
      • Idiopathic Pulmonary Fibrosis
      • EGCG + Nintedanib
      • +2 more
      • San Francisco, California
        UCSF Parnassus
      Apr 25, 2022

      Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis Trial (Hyperpolarized Xe129)

      Withdrawn
      • Idiopathic Pulmonary Fibrosis
      • Hypersensitivity Pneumonitis
      • Hyperpolarized Xe129
      • (no location specified)
      Sep 6, 2022

      Idiopathic Pulmonary Fibrosis Trial in Worldwide (PRM-151, )

      Completed
      Has Results
      • Idiopathic Pulmonary Fibrosis
      • PRM-151
      • placebo
      • San Francisco, California
      • +17 more
      Mar 31, 2022